New drug cocktail takes on superbugs in major trial
Disease control
Completed
This study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best current treatments for serious infections like urinary tract, kidney, lung, and abdominal infections caused by carbapenem-resistant bacteria. 126 adults participated.…
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC